Furthermore, in comparison to mildly infected patients, severe COVID-19 patients showed an increase in the populations of the highly inflammatory monocyte-derived FCN1+ macrophages in their Broncho Alveolar Lavage Fluid (BALF) and the CD14+CD16+ inflammatory monocytes in their peripheral blood [59]. This evidence concerns the gene CD14 and COVID-19.